Our research spans more than 15 years investigating the importance of saccade data as biomarkers for the diagnosis of mental illness
Biomarkers have the potential to revolutionize the diagnosis and management of psychiatric disorders which affects 1 in 5 of us during our lifetime. The present symptom based diagnoses are unreliable with more than 50% of cases misdiagnosed at first presentation leading to suboptimal, inappropriate or even dangerous treatments.
We have developed SaccScan, a point-of-care tool, which has been demonstrated to detect Schizophrenia and related illnesses with better than 95% accuracy. Early economic modelling showed that early detection of schizophrenia using SaccScan could produce savings of £33,474 per patient in the case of suspected schizophrenia alone.
We have done extensive research on exploring SaccScan data to diagnose mental health condition. This could be a potentially useful approach to diagnose mental health condition at an early stage.